Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025)

Roivant Sciences (ROIV) reported Interest & Investment Income of $43.3 million for Q4 2025, down 30.05% on a YoY basis from $61.9 million in Q4 2024, and down 4.58% quarter-over-quarter from $45.3 million in Q3 2025.

Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025) Analysis & Trends

Roivant Sciences has reported Interest & Investment Income for 5 years, with the latest figure at $43.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 30.05% year-over-year to $43.3 million; the trailing twelve-month figure through Dec 2025 stood at $198.8 million (down 15.67% YoY), and the FY2026 full-year result was $178.1 million, down 31.07% from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $43.3 million, down from $45.3 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $72.1 million in Q2 2024, with the low at $62000.0 in Q3 2021.
  • Historically, Interest & Investment Income has averaged $30.1 million across 5 years, with a median of $24.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 15428.79% — and 2025, when it tumbled 35.02%.
  • Roivant Sciences' Interest & Investment Income stood at $66000.0 in 2021, then jumped by 15428.79% to $10.2 million in 2022, then soared by 211.77% to $32.0 million in 2023, then soared by 93.57% to $61.9 million in 2024, then sank by 30.05% to $43.3 million in 2025.
  • The last three Interest & Investment Income figures came in at $43.3 million (Q4 2025), $45.3 million (Q3 2025), and $48.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Roivant Sciences 21.82 Bn 22.59 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 43.27 Mn
Sep 30, 2025 45.34 Mn
Jun 30, 2025 48.32 Mn
Dec 31, 2024 61.85 Mn
Sep 30, 2024 69.77 Mn
Jun 30, 2024 72.13 Mn
Dec 31, 2023 31.95 Mn
Sep 30, 2023 14.30 Mn
Jun 30, 2023 16.72 Mn
Dec 31, 2022 10.25 Mn
Sep 30, 2022 5.67 Mn
Jun 30, 2022 1.98 Mn
Dec 31, 2021 66,000.00
Sep 30, 2021 62,000.00